Protein and Genome Sequencing brings Personalised Treatments a Step Closer

Posted on 12 May 2019

Researchers have created a publicly available catalogue containing 56,592 different protein mutations present in colon-cancer tissue, which could unearth important biomarkers to help doctors characterise different types of colon cancer.

Source: DOI: 10.1016/j.cell.2019.03.030

The analysis also flagged genes that were unusually active in cancerous tissue, including some that are known to have a role in tumour suppression. A reaction called phosphorylation helped to account for the elevated activity, so the authors suggest that curbing the reaction might return the proteins to their usual anti-cancer function.



  1. Suhas Vasaikar, Chen Huang et al. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities. Cell, 177, 4, 5 2019. DOI: 10.1016/j.cell.2019.03.030
Featured in This Post

Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

Checkout the Gowing Life Store

Scientifically Developed Blended Vitamins, and Exclusive Supplements For Health, and Longevity

Copyright © Gowing Life Limited, 2022 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.